Text Size

Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic Patients (IMPRESS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Aarhus
ClinicalTrials.gov Identifier:
NCT01538290
First received: February 20, 2012
Last updated: June 11, 2012
Last verified: June 2012
History of Changes
  Purpose

The investigators want to validate two non-invasive devices for the determination of central blood pressure, i.e. blood pressure in the aorta (artery leaving the heart).


Condition
Diabetes Mellitus, Type 2
Blood Pressure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Aarhus:

Enrollment: 34
Study Start Date: November 2011
Study Completion Date: March 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patient with type 2 diabetes mellitus referred to elective coronary angiography.

Criteria

Inclusion Criteria:

  • Diabetes Mellitus, Type 2
  • Age above 18 years

Exclusion Criteria:

  • Atrial fibrillation or other cardiac arrhythmia
  • known stenosis of aorta or arteria subclavia/brachialis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01538290

Locations
Denmark
Aarhus University Hospital, Skejby, Department of Cardiology
Aarhus, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Study Director: Hans Erik Bøtker, MD,Professor Aarhus University Hospital, Skejby, Department of Cardiology
  More Information

No publications provided

Responsible Party: University of Aarhus
ClinicalTrials.gov Identifier: NCT01538290     History of Changes
Other Study ID Numbers: M-20110166
Study First Received: February 20, 2012
Last Updated: June 11, 2012
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics

Keywords provided by University of Aarhus:
Calibration
Validation
Transfer function
SphygmoCor
Arteriograph

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 16, 2013